NCT00856258 - Multiple Dose Study in Healthy Volunteers to Assess Safety, Pharmacokinetics and Pharmacodynamics of PF 03882845 | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 31, 2009

Primary Completion Date

June 30, 2009

Study Completion Date

June 30, 2009

Conditions

Healthy Volunteers

Interventions

DRUG

PF 03882845 and Placebo

The constituted dosage form for all doses were suspensions of drug candidate. Doses were administered once daily for 10 consecutive days.

DRUG

PF 03882845 and Placebo

The constituted dosage form for all doses will be suspensions of drug candidate. Doses will be once daily for 10 consecutive days.

DRUG

PF 03882845 and Placebo

The constituted dosage form for all doses will be suspensions of drug candidate. Doses will be once daily for 10 consecutive days.

DRUG

PF 03882845 and Placebo

The constituted dosage form for all doses will be suspensions of drug candidate. Doses will be once daily for 10 consecutive days.

Trial Locations (1)

Pfizer Investigational Site, New Haven